# Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA)

> **NCT03887676** · PHASE2 · COMPLETED · sponsor: **Holland Bloorview Kids Rehabilitation Hospital** · enrollment: 90 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Arbaclofen
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03887676
- **Lead sponsor:** Holland Bloorview Kids Rehabilitation Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2023-08-04
- **Final completion:** 2023-08-04
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-07-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887676, "Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03887676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*